Remarkably, 59% of the so-called MYC/BCL2/BCL6-TH and 27% of MYC/BCL6-DH DLBCL are actually due to a direct genomic fusion between the MYC and BCL6 loci. Here, BCL2 is linked to diffuse large B-cell lymphoma.